5th International Conference on Heart and Cardiovascular Diseases

Preventive Cardiology at Heart Congress 2027 brings together clinicians and researchers working to identify cardiovascular risk before it becomes disease. Sessions cover the latest evidence on risk assessment, lifestyle medicine, and pharmacological prevention, giving attendees practical strategies to lower cardiovascular event rates in their own patient populations. The session also addresses emerging RNA-targeted therapies for lipoprotein(a) reduction, bempedoic acid in statin-intolerant patients, anti-inflammatory cardiovascular risk reduction with colchicine, and the social determinants driving cardiovascular health inequity.

Key Discussion Areas:

• How newer risk models (polygenic scores, coronary calcium, AI-based calculators) are reshaping who receives early treatment
• The evidence base for early statin, ezetimibe, and GLP-1 receptor agonist use in primary prevention
• Whether wearable and remote-monitoring data can meaningfully improve long-term adherence to prevention plans
• Persistent gaps between prevention guidelines and real-world primary care practice
• The influence of social determinants of health on unequal cardiovascular risk across populations
• How aggressively to treat borderline-risk patients as evidence thresholds shift

Sub Tracks

• Cardiovascular Risk Assessment
• Primary & Secondary Prevention
• Lifestyle & Behavioral Cardiology
• Nutrition & Cardiovascular Health
• Obesity & Cardiovascular Disease
• Smoking & Tobacco-Related Cardiovascular Risk
• Exercise & Physical Activity
• Sports Cardiology
• Cardiac Rehabilitation
• Geriatric Cardiology
• Cardiovascular Health & Aging
• Psychological & Mental Health in Cardiology
• Population Cardiovascular Health
• Health Disparities & Prevention
• Preventive Pharmacotherapy

Why Attend This Session?

Cardiologists, primary care physicians, public health researchers, and epidemiologists will find practical, evidence-based prevention protocols they can apply directly in practice. The track offers a platform to present risk-reduction research, engage with prevention-focused societies, and build collaborations aimed at reducing population-level cardiovascular disease burden.

Related Topics

Cardiometabolic & Lipidology | Clinical Cardiology & Hypertension | Women's Cardiovascular Health | AI & Digital Cardiology

Frequently Asked Questions:

Q: What does the Preventive Cardiology track cover at Heart Congress 2027?

A: It covers cardiovascular risk assessment, lifestyle medicine, pharmacological prevention, and population-level screening programs, with a focus on translating evidence into everyday clinical practice.

Q: Who should attend the Preventive Cardiology sessions?

A: Preventive cardiologists, primary care physicians, public health researchers, and care teams involved in cardiovascular risk management.

Q: Does this track include lifestyle and behavioral interventions?

A: Yes. Lifestyle Medicine and Behavioral Interventions is a dedicated sub-track covering diet, exercise, and adherence-focused programs.